Skip to content
Parakho

Q1 FY27, unaudited

Revenue
₹403.02 Cr
Profit after tax
₹27.76 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations403.02+19.87%1,302.97
Other income5.90−10.61%36.88
Total income408.92+19.28%1,339.85
Employee benefit expense27.12+13.19%94.17
Finance costs0.30−18.92%1.39
Depreciation & amortisation13.73+0.44%54.85
Total expenses371.83+16.31%1,258.44
Profit before tax37.09+60.29%76.02
Tax expense9.33+58.67%20.39
Profit after tax27.76+60.83%55.63
Total comprehensive income57.50+146.46%42.42
Earnings per share
Earnings per share, basic₹1.66₹3.33
Earnings per share, diluted₹1.66₹3.32

Q1 FY27 unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base unaudited, from the company’s filing with NSE. Source

FY26 from the company’s filing with NSE. Source

Earnings call

Q1 FY27

NOCIL reported Q1 FY27 revenue of Rs 403 crores, up 20% year-on-year and 22% sequentially, driven by 9% volume growth and higher selling prices linked to raw material costs. EBITDA rose 48% YoY to Rs 45 crores with margins at 11.2%, while PAT grew 61% YoY to Rs 28 crores. Management discussed anti-dumping duty developments on Sulphonamides and Pilflex 13, progress at the new TDQ plant in Dahej, and gave revenue and margin guidance for FY27.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 45 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 25 Aug 2026.

NOCIL Ltd (NOCIL) — filings and results · Parakho